BioWorld

Tag Archives: ROI

The Public ROI from Drug Prices

May 16, 2011 – 10:16 pm

Biopharma is often the scapegoat for the escalating cost of healthcare, especially when it comes to the price of brand drugs. But since it’s hard to put a price on health and a long life, what gets lost in this…

Share
By Mari Serebrov | Posted in Big pharma, Biotechnology, Drug Approval, FDA, Healthcare reform, Orphan disease, Pharmaceutical | Also tagged | Comments (0)

Bad Behavior has blocked 819 access attempts in the last 7 days.